Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125789251 | 12578925 | 1 | I | 20160425 | 20160713 | 20160721 | 20160721 | EXP | IT-ACTAVIS-2016-15580 | ACTAVIS | 89.83 | YR | M | Y | 0.00000 | 20160721 | CN | IT | IT |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125789251 | 12578925 | 1 | PS | Zoledronic Acid | ZOLEDRONIC ACID | 1 | Intravenous (not otherwise specified) | 4 MG, ONCE A MONTH | UNKNOWN | 202472 | 4 | MG | CONCENTRATE FOR SOLUTION FOR INFUSION | /month |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125789251 | 12578925 | 1 | Metastases to bone |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
125789251 | 12578925 | DE |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125789251 | 12578925 | Hepatic failure | |
125789251 | 12578925 | Jaundice cholestatic |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |